Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aromatase Inhibitors: Skeletal Effects and the Role of CYP19 Gene Polymorphisms

NCT00603967 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00603967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00603967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aromatase Inhibitors: Skeletal Effects and the Role of CYP19 Gene Polymorphisms
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2006
Completion date
October 31, 2009
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, postmenopausal